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Abstract: The use of herbomineral formulation in the healthcare sector for different chronic diseases is gaining popularity 
due to its fewer side effects, high safety profile, and cost effectiveness. A new proprietary herbomineral formulation was 
formulated, consisting of four essential ingredients viz. herbal root extract (ashwagandha), and minerals (zinc, magnesium, and 
selenium). The study aims to evaluate the in vitro effect of Biofield Energy Healing (The Trivedi Effect
®
) on the test 
formulation using murine dendritic (DCs) and splenocyte cells. The herbomineral formulation was divided into two parts; one 
was represented as control, while the other part was treated with the Biofield Energy Healing Treatment remotely by eighteen 
renowned Biofield Energy Healers (The Trivedi Effect
®
) and defined as the Biofield Treated formulation. The effect of the test 
formulation on these cells were monitored by an estimation of pro-inflammatory cytokines level such as tumor necrosis factor 
(TNF-α), macrophage inflammatory protein (MIP-1α), and interleukin (IL-1β) in cell culture supernatants at the non-cytotoxic 
concentrations of the test formulation using MTT assay. The DCs were treated with the Biofield Energy Treated test 
formulation at different concentrations (i.e. 1.05 to 1052.5 µg/mL) for 24 hours, and the results showed significant (p≤0.001) 
suppression of TNF-α levels at all the tested concentrations with a maximum percentage decrease by 43.64% at 5.2 µg/mL 
concentration in the Biofield Treated formulation as compared with the untreated test formulation. Further, the Biofield Treated 
formulation also demonstrated inhibition of MIP-1α and IL-1β at a concentration range of 0.0000105 to 10.5 µg/mL in LPS 
stimulated splenocyte cells. There was a significant (p≤0.001) inhibition of MIP-1α (26.52%) and IL-1β (35.28%) in the 
Biofield Treated test formulation at concentration 0.000105 µg/mL and 0.0000105 µg/mL, respectively in comparison to the 
untreated test formulation. Overall, these results suggest that the Biofield Energy Healing based herbomineral formulation (The 
Trivedi Effect
®
) significantly down-regulated the tested cytokines expression in DCs and splenocyte cells as compared to the 
untreated formulation. Therefore, the Biofield Healing based formulation might be useful as a better anti-inflammatory product 
for many chronic and acute inflammatory disease conditions and autoimmune disorders. The Biofield Energy Treatment based 
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formulation can also be effectively applied in cases of organ transplants, stress management and anti-aging by improving 
overall health. 
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1. Introduction 
In the last few years, there has been exponential growth 
reported in the herbal medicine sector. In developing and 
developed countries alike, medicinal plant-derived drugs are 
gaining popularity due to their natural origin and less side 
effects. Many traditional and complementary medicines 
currently in use are derived from medicinal plants, minerals, 
and organic matter, which are commonly used for the 
prevention and treatment of many diseases [1]. However, the 
use of traditional remedies has gained importance in cases 
when conventional medicine is ineffective for certain 
diseases, due to being widely perceived as natural, safe, and 
non-toxic. Herbal and traditional medicine are suitable 
candidates for new therapeutics due to their vast chemical 
diversity and various biological effects [2]. Withania 
somnifera (ashwagandha) is an important medicinal plant 
that belongs to the family Solanaceae. It is commonly known 
as Indian ginseng and is used for various treatments in 
alternative therapy [3]. Withanolides have been reported as 
major active constituents that are isolated from the root and 
leaves of the ashwagandha plant for biological activity [4]. 
Apart from its important antibacterial activity, several reports 
have demonstrated its potent immunomodulatory and anti-
tumor activity [5]. Preclinical and clinical studies report that 
each of the active constituents of ashwagandha have shown 
immunomodulatory effects in various inflammatory diseases 
[6], but the mechanisms of anti-
inflammatory/immunomodulation remain unknown. 
However, reports have shown that the role of trace elements 
is significant in immunomodulation due to their strong 
interaction with the immune system. Selenium, zinc, copper, 
and magnesium, etc. are highly recommended trace elements 
because of their immunomodulatory impact [7]. The 
coordinated interactions of these molecules with the immune 
cells may evoke an appropriate immune response. 
In order to design a traditional medicine therapy, it is 
important to understand how herbal medicine effectively 
impacts disease [8]. Recently, we prepared a new proprietary 
herbomineral formulation, which consists of a combination 
of the herbal root extract ashwagandha and minerals (zinc, 
magnesium, and selenium). These different ingredients of the 
test formulation possess significant anti-inflammatory, 
antioxidant, anti-infective, anti-viral and immune-modulating 
properties [5, 7, 9, 10], which plays a key role in protecting 
cells from oxidative stress. Based on recent literature, it was 
reported that the herbomineral formulation had exhibited the 
level of phagocytic index and improved antibody titre to 
suggest a significant immunomodulatory response. Further, it 
was reported that the effect was potentiated in the presence 
of minerals [11], which can be useful for immune-
compromised patients, autoimmune disorders, and cancer; 
for promoting anti-stress and anti-aging; and in reducing the 
risk of cardiovascular diseases on a long term basis. 
The different type of immune cells such as dendritic cells 
(DCs), macrophages, and spleen can play an important role 
in order to stop the acute/chronic inflammation and retrieve a 
steady state strategy through the secretion of immuno-
modulating cytokines [12]. These immune cells have been 
reported to be useful as cellular models for in vitro studies. 
To initiate the adaptive immune response, DCs are reported 
to play an important role against different pathogens such as 
bacteria, viruses, and fungi [13]. DCs play an important role 
in regulating the immune system and are regarded as potent 
antigen-presenting cells (APC) to maintain and induce the 
primary immune response [14]. T helper (Th) cells regulate 
the immune function through the production of cytokines 
during infectious, allergic, or autoimmune diseases. These 
cells regulate the protective and pathological immune 
responses [15]. Using different types of cytokine production 
in vitro or ex vivo, the molecular mechanism of Th cells can 
be studied using murine splenocyte cells [16]. Here, murine 
bone marrow derived dendritic (BMDCs) and splenocyte 
cells were used to assess the effect of the Biofield Treated 
formulation on in vitro cell cultures. 
In recent years, Biofield Energy Treatment (The Trivedi 
Effect
®
) has been reported worldwide as an alternative 
treatment method which has been known for its significant 
impact on various cancerous cells [17]. According to many 
scientific studies, Biofield Energy Healing has been reported 
to have significant outcomes that may prove to be a more cost 
effective alternative to other approaches [18]. Complementary 
and Alternative Medicines (CAM) are now rising as preferred 
models of treatment, among which Biofield Therapy (or 
Healing Modalities) is one approach that has been reported to 
have several benefits to enhance physical, mental and 
emotional human wellness. However, Biofield Energy can 
exist in different forms such as kinetic, magnetic, potential, 
electrical, and electromagnetic. The human body has the 
power to produce low intensity electromagnetic signals known 
as the Biofield. Thus, a human has the ability to harness 
energy from the environment and transmit it to any living or 
nonliving object (s) around the globe. The objects always 
receive the energy and respond in a useful way. This process is 
known as Biofield Energy Healing Treatment (The Trivedi 
Effect
®
). Based on the literature data, Biofield Energy 
Treatment in terms of a Complementary and Alternative 
Medicine (CAM) approach was practiced worldwide [19] in 
addition to herbal medicine. The National Center of 
Complementary and Integrative Health (NCCIH) has 
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recognized and accepted Biofield Energy Healing as a 
complementary and alternative medicine (CAM) health care 
approach in addition to other therapies, medicines and 
practices such as natural products, deep breathing, yoga, Tai 
Chi, Qi Gong, chiropractic/osteopathic manipulation, 
meditation, massage, special diets, homeopathy, progressive 
relaxation, guided imagery, acupressure, acupuncture, 
relaxation techniques, hypnotherapy, healing touch, movement 
therapy, pilates, rolfing structural integration, mindfulness, 
Ayurvedic medicine, traditional Chinese herbs and medicines, 
naturopathy, essential oils, aromatherapy, Reiki, cranial sacral 
therapy and applied prayer (as is common in all religions, like 
Christianity, Hinduism, Buddhism and Judaism). To this day, 
Biofield Energy Healing has had significant impact in the 
transformation of living organisms and nonliving materials 
including metals, polymers, ceramics, chemicals, and 
pharmaceutical compounds. Even further, Biofield Energy 
Healing Treatment (The Trivedi Effect
®
) has been published in 
numerous peer-reviewed science journals due to its significant 
impacts in the science fields of biotechnology, genetics, 
cancer, microbiology, materials science and agriculture. 
In this study, the authors sought to explore the impact of 
Biofield Energy Healing (The Trivedi Effect
®
) on a 
herbomineral formulation and its immunomodulatory 
properties. Therefore, the study objective was to investigate 
the effect of a Biofield Treated and untreated test formulation 
on pro-inflammatory cytokines expression in in vitro cellular 
models (i.e., mice dendritic and splenocyte cells) using 
modern scientific methods. 
2. Material and Methods 
2.1. Chemicals and Reagents 
Lipopolysaccharide (LPS), 3-(4, 5-diamethyl-2-thiazolyl) 
2, 5 diphenyl-2 H-tetrazolium) (MTT), RPMI-1640, L-
glutamine, penicillin, streptomycin, HEPES, and 2- 
mercaptoethanol were purchased from Sigma Chemical 
Company (St. Louis, MO), a subsidiary of Sigma-Aldrich 
Corporation. ELISA assay kits (enzyme-link immunosorbent 
assay) for all cytokines TNF-α, MIP-1α, and IL-1β were 
purchased from R&D systems, USA. Fetal bovine serum 
(FBS) was purchased from GIBCO, USA. Ashwagandha 
(Withania somnifera) root extract powder (≥ 5% of total 
withanolides) was procured from Sanat Products Ltd., India. 
Zinc chloride and magnesium (II) gluconate hydrate was 
procured from Tokyo Chemical Industry Co., Ltd. (TCI, 
Japan). Sodium selenate was procured from Alfa Aesar, 
USA. Rapamycin, MTT, NaHCO3, and EDTA were procured 
from Sigma, USA. All other chemicals used were of 
analytical grade available locally in India. 
2.2. Experimental Design and Reference Standard 
The herbomineral test formulation contained the 
combination of four ingredients including ashwagandha root 
powder extract, zinc chloride, sodium selenite, and 
magnesium gluconate. Different concentrations of the test 
formulation were used for the study i.e. concentration range 
of 1.05 to 1052.5 µg/mL for bone marrow DCs and 
0.0000105 to 10.5 µg/mL with LPS stimulated splenocyte 
culture for cell viability assay. LPS was used as an 
immunostimulatory agent, while rapamycin was used as a 
reference standard (positive control) for immunosuppressive 
action in splenocyte cells assay. DCs were treated with 0.1% 
DMSO as a vehicle control group for the estimation of TNF-
α. MIP-1α and IL-1β were estimated in splenocyte cells, 
which includes splenocyte cells treated with LPS (0.5 
µg/mL) along with 0.005% DMSO, and was defined as the 
vehicle control group. 
2.3. Biofield Energy Treatment Strategies 
One part of the test formulation was treated with Biofield 
Energy by renowned Biofield Healers (also known as The 
Trivedi Effect
®
) and coded as the Biofield Energy Treated 
formulation, while the second part of the test formulation did 
not receive any sort of treatment and was defined as the 
untreated test formulation. This Biofield Energy Treatment 
was provided through a group of eighteen Biofield Energy 
Healers who participated in this study and performed the 
Biofield Energy Treatment remotely. Eleven Biofield Energy 
Healers were remotely located in the U. S. A, four were 
remotely located in Canada, two in Finland, and one of 
which was remotely located in Albania, while the test 
herbomineral formulation was located in the research 
laboratory of Dabur Research Foundation near New Delhi in 
Ghaziabad, India. This Biofield Treatment was administered 
for 5 minutes through the Healer’s unique Energy 
Transmission process remotely to the test formulation under 
laboratory conditions. None of the Biofield Energy Healers 
in this study visited the laboratory in person, nor had any 
contact with the herbomineral samples. Further, the control 
group was treated with a “sham” healer for comparative 
purposes. The sham healer did not have any knowledge about 
the Biofield Energy Treatment. After that, the Biofield 
Energy treated and untreated samples were kept in similar 
sealed conditions and used for the in vitro study on DCs and 
splenocytes for cytokines estimation. 
2.4. Experimental Animal 
C57BL/6 male mice were purchased from Vivo Bio Tech 
Ltd., Hyderabad, India and acclimatized for one week prior to 
the experiments. Rodent laboratory diet and drinking tap water 
were provided ad libitum under controlled conditions with a 
temperature of 22 ± 3°C, humidity of 30% to 70% and a 12-
hour light/12-hour dark cycle. All the procedures were in strict 
accordance with the Guide for the Care and Use of Laboratory 
Animals published by the US National Institutes of Health. 
Approval of the Institutional Animal Ethics Committee has 
been obtained prior to the animal experiments. 
2.5. Mouse Bone Marrow-Derived Dendritic Cells 
(BMDCs) Cultures 
C57BL/6 male mice were euthanized by CO2 
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asphyxiation. Subsequent experimental steps were conducted 
in a laminar air flow. BMDCs were induced from bone 
marrow (BM) cells using the modified method of Inaba K, et 
al., 1992 [20]. Briefly, a single cell suspension was prepared 
from BM obtained from femurs. After removing all muscle 
tissues with gauze from the femurs, the bones were placed in 
a 90 mm dish with 70% alcohol for 1 minute, washed twice 
with phosphate buffer saline (PBS), and transferred into a 
fresh dish with RPMI 1640. Both ends of the bones were cut 
with scissors in the dish, and flushed with 2 mL of RPMI 
1640 using a syringe and 25-gauge needle. The tissue was 
suspended, passed through nylon mesh to remove the debris 
and small bone pieces, and red blood cells were lysed with 
ammonium chloride. After washing, the lymphocytes and 
various other cells were killed with the cocktail of 
monoclonal antibodies (mAbs), and rabbit complement for 
60 min at 37°C. After that whole BM cells (2×10
6
 cells/mL) 
were cultured in RPMI 1640 medium in 90 mM petri dishes 
(Sigma Aldrich, St. Louis, MO) at 37ºC, 5% CO2, 
supplemented with 10% fetal bovine serum (FBS), 2 mM L-
glutamine, 100 U/mL penicillin G, 100 mg/mL streptomycin, 
and 20 ng/mL recombinant mouse granulocyte-macrophage 
colony-stimulating factor (GM-CSF) (R & D systems Inc., 
USA). Cells were incubated for 24 hours. Petri plates were 
then gently swirled and the medium containing non-adherent 
cells was removed and replaced with nutrient medium with 
similar procedure. The supplemented medium was replaced 
at every three-day interval. On day 6, non-adherent and 
loosely adherent DCs were harvested by gentle pipetting for 
further assays. The cell counts were performed using a 
hemocytometer and cell viability was determined using the 
trypan-blue dye exclusion technique with the results showing 
≥95% of viable cells. Cells were cultured in 96-well tissue 
culture plates with 5 x 10
3
 cells per well. They were 
incubated at 37ºC in a humidified atmosphere of 5% CO2 for 
the indicated period. The respective vehicle controls 
(DMSO) were kept in the assay for comparison. 
2.6. Mouse Splenocyte Cultures 
C57BL/6 male mice were sacrificed and their spleens were 
aseptically removed and grounded by passing through a 
sterile plastic strainer under aseptic conditions. After the cells 
were centrifuged twice at 1000 g for 5 minutes, erythrocytes 
were lysed by lysis buffer (0.15 M NH4Cl, 0.01 M NaHCO3, 
and 0.1 mM EDTA, pH 7.4) and then cell pellets were 
washed twice with RPMI-1640 medium. Further, the cells 
were resuspended in complete RPMI-1640 medium (RPMI 
1640 medium plus 10% fetal bovine serum, 2 mM glutamine, 
100 IU/mL of penicillin and streptomycin, 15 mM HEPES 
and 50 mM 2-mercaptoethanol). The cell counts were 
performed using a hemocytometer and cell viability was 
determined using the trypan-blue dye exclusion technique 
with the results showing ≥95% of viable cells. Cells were 
cultured in 96-well tissue culture plates with 0.2 x 10
6
 cells 
per well. They were incubated at 37°C for 24 hours in a 
humidified atmosphere of 5% CO2 for the indicated period 
[21]. The respective vehicle controls (DMSO) were kept in 
the assay for comparison. 
2.7. Cytotoxicity by MTT Assay 
The number of viable cells is determined by the ability of 
mitochondria to convert MTT to formazan dye. Both the 
cells were cultured overnight in 96-well plates, at a density of 
5 x 10
3
 cells per well for BDMCs and 0.2 x 10
6
 cells per well 
for splenocyte cells. After the treatment and incubation 
period, the medium was removed, with 20 µL of 5 mg/mL 
MTT then added to each well, and incubated for 3 hours 
further, at 37ºC in a humidified 5% CO2 atmosphere. The 
cells were centrifuged and supernatants were removed. The 
cell pellet in each well was resuspended in 150 µL of DMSO 
to dissolve formazan crystals. The optical density of each 
well was read at 540 nm using Biotek Reader 
(SIAFRT/Synergy HT multimode reader, US). 
The effect of the test formulation on cell viability of DCs 
and splenocyte cells was determined as- 
%	Cell	viability = 100 −%	cytotoxicity 
Where; % cytotoxicity=[(O. D. of control cells–O. D. of 
cells treated with the test formulation)/O. D. of control 
cells]*100. 
The concentration that resulted in >75% viability was 
selected for subsequent cytokine estimation. 
2.8. Cytokines Assays Using ELISA Method 
The effect of the Biofield Treated and untreated test 
formulations on the production of TNF-α, MIP-1α, and IL-1β 
was measured by an enzyme-linked immunosorbent assay 
(ELISA) using culture supernatants collected from treated 
cells. Briefly, ELISA plates were coated overnight at 4ºC 
with an antibody in coating buffer at the recommended 
concentration. After washing with PBS-T (PBS with 0.05% 
Tween 20), the plates were blocked with assay diluent for at 
least 2 hours at room temperature. A total of 100 µL culture 
supernatant from different experimental samples and 
standards were incubated overnight at 4ºC and, after three 
washes, biotinylated anti-mouse cytokine (TNF-α, MIP-1α, 
and IL-1β) antibodies at the recommended concentrations 
were incubated for 1 hour at room temperature. The plate 
was incubated for 45 minutes at room temperature with 
gentle shaking. The plates were again washed 3 times and 
then 100 µL of horseradish per-oxidase (HRP)–streptavidin 
conjugate solution was added and the plate was incubated for 
45 minutes at room temperature with gentle shaking. Next, 
the plate wells were washed 3 times as previous and 100 µL 
of 3, 3, 5, 5'-tetramethylbenzidine (TMB) one-step substrate 
reagent was added followed by 30 minutes incubation at 
room temperature in the dark. Then 50 µL of 0.2 mole/L 
sulphuric acid was added to each well to stop the reaction 
and the plates were read for absorbance at 450 nm using a 
Biotek reader (SIAFRT/Synergy HT multimode reader). 
Standards were run in parallel to the samples, and the 
concentrations were determined in triplicates. 
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2.8.1. TNF-alpha Level in Dendritic Cells (DCs) 
DCs were seeded in a 24-well plate at a density of 0.5 x 
106 cells per well with 1 mL of culture medium and co-
incubated for 24 hours with different non-cytotoxic 
concentrations ranging from 1.05 to 105.2 µg/mL of the 
Biofield Treated and untreated test formulations. DCs treated 
with 0.1% DMSO were included as a vehicle control. After 
24 hours of incubation, cell-free culture supernatants were 
collected and analyzed for the TNF-α using ELISA as per the 
manufacturer’s instructions [22]. The concentrations were 
determined for two wells in each sample in triplicate. 
2.8.2. MIP-1α and IL-1β in Splenocyte Cells 
For the estimation of MIP-1α and IL-1β in LPS induced 
splenocyte, the cells (2 x 10
6
 cells/well in 24-well culture 
plates) were treated with the Biofield Energy Treated and 
untreated test formulations at selected non-toxic 
concentrations (0.0000105 to 1.05 µg/mL) in triplicate. 
Splenocyte cells were treated with LPS (0.5 µg/mL) along 
with 0.005% DMSO were included as control cells. 
Rapamycin was included as a positive control. After 48 hours 
of incubation, supernatants were analyzed for the secreted 
levels of MIP-1α and IL-1β using ELISA as per the 
manufacturer’s instructions [22]. 
2.9. Statistical Analysis 
Data were expressed as mean ± SEM and were subjected 
to Student’s t-test for two group comparison. Statistical 
significance was considered at p≤0.05. 
3. Results 
3.1. In Vitro Immune Cells Viability Assay by MTT Assay 
The effect of the Biofield Energy Treated and untreated 
test formulations on the proliferation of DCs and splenocyte 
cells were examined using MTT cell viability assay. The 
effect of the Biofield Treated and untreated test formulations 
on viabilities of DCs and splenocyte cells are shown in 
Figure 1 and 2, respectively. The untreated test formulation at 
concentrations 1.05 µg/mL and 5.2 µg/mL showed 120.8% 
and 141% cell viability, respectively in DCs. The increased 
cell viability with respect to the vehicle control might be due 
to the proliferation in cell cultures. Further concentration 
dependent increase in cell viability was observed till 5.2 
µg/mL of the untreated test formulation. However, further 
increase in concentration resulted in reduced viability up to 
76.3% at concentration 105.2 µg/mL. Therefore, the 
concentration range from 1.05 to 105.2 µg/mL were selected 
for cytokines estimation with cell viability more than 75%. 
Similarly, the Biofield Energy Treated test formulation 
showed increased percentage of cell viability pattern with 
higher concentrations as compared with the untreated test 
formulation at 51.2 and 105.2 µg/mL. It was suggested that 
the decreased trend of cell viability in DCs with respect to 
the increased concentration of the test formulation after 24 
hours as compared with the vehicle control. 
 
Figure 1. MTT assay in dendritic cells after 24 hours of treatment with different concentrations of the test formulation. The absorbance of the MTT formazan 
was determined at 540 nm in an ELISA reader. Cell viability was defined as the absorbance ratio (expressed as a percentage) of the formulation treated cells 
relative to the untreated vehicle cells. 
The splenocyte cells were treated with the Biofield Treated 
and untreated test formulations in the concentration range from 
0.0000105 to 10.5 µg/mL in the presence of LPS (0.5 µg/mL) 
for 48 hours. The effect of the Biofield Energy Treated and 
untreated test formulations on the viability of splenocyte cells 
showed an alteration with respect to different concentrations of 
the test formulations after 48 hours as compared with the 
vehicle control. The result of the percent cell viability is 
presented in Figure 2. Further, the cytokines analysis was 
conducted using these concentration ranges. The percentage 
viability of LPS alone at 0.5 µg/mL was 122.8%, while 
rapamycin (reference standard of immunosuppressive agent) 
showed 74.2% and 81.6% cell viability at 1 and 10 nM, 
respectively. Both the Biofield Treated and untreated test 
formulations showed more than 82% cell viability up to 
concentration at 1.05 µg/mL. So, the concentration range of 
the test formulation from 0.0000105 to 1.05 µg/mL was 
selected for cytokines (MIP-1α and IL-1β) estimation. 
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Figure 2. MTT assay in splenocyte cells after 48 hours of treatment with various concentrations of the test formulation in the presence of 0.5 µg/mL LPS. The 
absorbance of the MTT formazan was determined at 540 nm in an ELISA reader. Cell viability was defined as the absorbance ratio (expressed as a 
percentage) of formulation treated cells relative to untreated vehicle cells. 
3.2. Effect of Herbomineral Formulation on the Expression 
of Pro-inflammatory Cytokines TNF-α, MIP-1α, and 
IL-1β in Immune Cells 
Lymphocyte proliferation and the activation of NK cells 
are cytokine dependent [23]. The type of cytokine up/down 
regulation affects the course of immune response and the 
whole network of immune regulation. The pro-inflammatory 
cytokines such as TNF-α, MIP-1α, and IL-1β play a pivotal 
role in inflammation, immune modulation, and lymphocyte 
activation. Various herbomineral formulations have the 
potential to modulate the expression and activation of 
cytokines. Therefore, an experiment was conducted to 
observe the expression TNF-α, MIP-1α, and IL-1β at two 
different immune cells, such as dendritic and spleen cells, 
after exposure to the Biofield Treated and untreated test 
formulations. To examine the effect of the test formulation on 
the production of the pro-inflammatory cytokines, TNF-α, 
MIP-1α, and IL-1β, mice bone marrow derived dendritic 
cells and spleen cells were incubated with various 
concentrations of the Biofield Energy Treated and untreated 
test formulations in DCs and splenocytes for 24 hours and 48 
hours, respectively. The production of the cytokines by these 
immune cells was tested in the culture supernatants using 
commercial ELISA kits. 
 
 
3.3. Modulation of TNF-α Expression in Mouse Dendritic 
Cells (DCs) 
The effect of the Biofield Treated test formulation on TNF-α 
secretion in DCs is represented in Figure 3. Both the untreated 
and Biofield Energy Treated test formulation groups 
demonstrated significant decrease in the level of TNF-α 
secretion at different tested concentrations i.e. at 5.2, 10.5, 25.6, 
51.2, and 105.2 µg/mL, which indicated decrease in the level of 
pro-inflammatory cytokine expression in the presence of the test 
formulation as compared to the vehicle control group. The 
maximum fall in TNF-α concentration was reported at 5.2 
µg/mL (p≤0.001) and showed a statistically significant 
difference. The untreated test formulation showed 110.7 pg/mL, 
while the Biofield Energy Treated test formulation showed 63.5 
pg/mL of TNF-α at 5.2 µg/mL, which suggests that the Biofield 
Treated test formulation showed a better effect and decreased 
the TNF-α level by 43.64% as compared to the untreated test 
formulation. Further, the level of TNF-α was decreased from 
60.3 ± 1.07 (untreated test formulation) to 38.7 ± 5.35 (Biofield 
Treated test formulation) and showed statistical significance at 
10.5 µg/mL (p≤0.05) of both the treated and untreated test 
formulations. The Biofield Treatment enhanced the down-
regulation of pro-inflammatory cytokines of TNF-α expression 
in DCs as compared to the untreated test formulation at different 
concentrations (Figure 3). 
 
Figure 3. Concentration-dependent inhibition of TNF-α by the Biofield Treated formulation in mice dendritic cells. For each concentration treatment, the level 
of TNF-α release was measured after 24 hours of treatment. The values are represented in pg/mL as mean ± SEM (***p≤0.001 and *p≤0.05 as compared with 
the untreated test formulation). 
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3.4. Modulation of MIP-1α and IL-1β Expression in Mouse 
Splenocytes 
Splenocytes were isolated from the male mice and were 
cultured in vitro in RPMI-FBS (10%) with LPS and the 
levels of MIP-1α and IL-1β cytokines were measured by 
ELISA in the culture supernatants. The effect of the Biofield 
Treated formulation on cytokine production was observed at 
various tested concentrations of the Biofield Treated and 
untreated samples. Rapamycin was used as a positive control. 
As shown in Figures 4 and 5, the effect for both cytokine 
MIP-1α and IL-1β production after LPS stimulation was 
increased and the major effect was observed after the culture 
period of 48 hours. 
 
3.4.1. MIP-1α Activity 
The effect of the Biofield Energy Treated and untreated 
test formulation on MIP-1α secretion is shown in Figure 4, 
which demonstrates the comparative effect of the Biofield 
Energy Treated and untreated test formulation on MIP-1α 
secretion in splenocyte cells. Both the untreated and treated 
test formulations demonstrated inhibition of MIP-1α 
expression as compared to the LPS stimulated cells. 
However, the Biofield Energy Treated test formulation 
improved the down-regulation of MIP-1α. At concentration 
0.000105 µg/mL, maximum decreased level of MIP-1α was 
reported i.e. 26.52% in the Biofield Treated formulation 
(p≤0.05), while at 0.105 µg/mL it showed 21.05% decreased 
(p≤0.001), which exhibited better immunosuppressive 
activity compared with the untreated test formulation. 
 
Figure 4. Concentration-dependent inhibition of LPS mediated production of MIP-1α by the Biofield Treated formulation in mice splenocyte cells. For each 
concentration treatment, the level of MIP-1α release was measured after 48 hours of treatment. The values are represented in pg/mL as mean ± SEM (*p≤0.05 
and ***p≤0.001 as compared with the untreated test formulation). 
3.4.2. IL-1β Activity 
The overall effect of the test formulation on IL-1β 
secretion is represented in Figure 5. The figure demonstrates 
the comparative effect of the Biofield Energy Treated and 
untreated test formulations on IL-1β secretion. Both the 
untreated and Biofield Treated test formulations 
demonstrated inhibition of IL-1β as compared to the LPS 
stimulated cells. At all the tested concentrations, the Biofield 
Energy Treated test formulation exhibited better inhibition of 
IL-1β secretion compared with the untreated formulation. 
The maximum suppression (35.28%) of IL-1β was reported 
at 0.0000105 µg/mL (p≤0.001), while all the tested 
concentrations were statistically significant with respect to 
the untreated formulation. 
 
Figure 5. Concentration-dependent inhibition of LPS mediated production of IL-1β by the Biofield Treated formulation in mice splenocyte cells. For each 
concentration treatment, the level of IL-1β release was measured in cell supernatant after 48 hours of treatment. The values are represented in pg/mL as mean 
± SEM (*p≤0.05 and ***p≤0.001 as compared with the untreated test formulation). 
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4. Discussion 
The use of herbomineral products to maintain or improve 
health has gradually increased across the globe. Moreover, 
the formulation of new products that have the ability to 
improve the overall health by reducing inflammation is 
essential because of the potential for long-term effectiveness, 
decreased toxicities, and lower costs. Herbal extracts have 
been shown to modulate immune responses during 
inflammation. A new proprietary natural herbomineral 
formulation was designed in this study, which might be 
better utilized to regulate immune function as it contains the 
essential minerals required to modulate immunity. 
The individual constituents of this test formulation have 
been shown to modulate the inflammatory parameters 
specifically using cytokine alteration [5, 7, 9, 10]. For 
example, ashwagandha was shown to inhibit NF-κB and AP-
1 transcription factors in human peripheral blood and 
synovial fluid mononuclear cells in a study conducted by 
Singh et al., 2007 [24]. Zinc deficiency influences the 
generation of cytokines, including IL-2, IL-6, IL-1β, and 
TNF-α. Further, zinc supplementation results in changed 
plasma cytokines that exhibit a concentration-dependent 
response. The mechanism through which zinc showed this 
ability either induces or inhibits the activation of NF-κB. The 
wide involvement of zinc in the immune system includes an 
ability to influence the production and signaling of numerous 
inflammatory cytokines in a variety of cell types [25]. 
Another important mineral of the test formulation was the 
magnesium gluconate, which was reported to reduce the 
cytokine production in the cases of intrapartum women and 
term and preterm neonates, suggesting the effectiveness in 
those at risk for inflammation-associated adverse perinatal 
outcomes, whereby magnesium plays a critical regulatory 
role in NF-κB activation, cytokine production, and disease 
pathogenesis [26]. Recently, Chen Y et al., 2009 reported 
that the supplementation of MC3T3-E1 with methylseleninic 
acid (MSA) decreased the activation of NF-kB results in 
decreased level of cytokines such as IL-6, MCP-1, COX-2 
and iNOS in response to MDA-MB-231 conditioned medium 
[27]. 
The authors of this study are trying to develop a 
herbomineral formulation, which can attribute to the 
immunomodulating effects and maintenance of the immune 
system. This may prevent the progression of acute or chronic 
infection. As infection starts, inflammation is the first 
response by the immune system. It is mainly caused by the 
release of cytokines for example TNF-α, IL-1, and IL-6, and 
eicosanoid such as PGE2. Thus, inhibitors of these cytokines 
have been considered as candidates for anti-inflammatory 
drugs. The evaluation on immune cells, especially in the BM 
cells such as dendritic and splenocyte cells, are always used 
as a standard to screen the potential immunomodulatory 
effect of a substance/product. This is the reason the thymus is 
regarded as the major primary lymphoid organ for the 
development of T cells, while bone marrow is for the 
matured B and NK cells. These immune cells then migrate to 
the spleen, which is the secondary lymphoid tissue, and 
respond to the antigens. Therefore, thymus and spleen cell 
proliferation are mainly regulated to maintain immune 
homeostasis, which might be considered an important marker 
for the control of the immune response [28]. 
Lymphocytes/monocytes/macrophages are mainly regarded 
as key mediators in inflammation and are widely distributed 
in the body. Therefore, mouse BM derived DCs and 
splenocyte cells, which represent appropriate model systems 
to study immune responses, were utilized to investigate the 
anti-inflammatory effects of a newly developed proprietary 
herbomineral formulation. 
It has been assumed that the Biofield Energy Healing 
results might be due to the electromagnetic/energy fields [29] 
that were emitted from the Biofield Healers during the 
Biofield Energy Treatment. The Trivedi Effect
®
 (Biofield 
Energy Treatment) has been reported worldwide with 
significant outcomes in many reasearch fields. Widespread 
studies were reported in case of cancer research [30, 31], 
altered antimicrobial sensitivity against pathogenic microbes 
was reported in microbiology [32-35], genetics [36, 37], 
altered physiochemical properties of important compounds in 
pharmaceutical science [38-42], improved crop productivity 
and quality of crops in agricultural science [43-45], and in 
changing the structure of the atom in relation to various 
polymers, ceramics, metals and chemicals in materials 
science [46-48], and much more. 
Biofield Energy Treatment, as an evidence-based 
integrative medicine therapy, has been reported to reduce the 
metastatis in cancer cell lines, and also showed significant 
reduction the level of cytokines such as IL-1α, monokine-
induced by gamma interferon (MIG), IL-1β, and macrophage 
inflammatory protein-2-alpha (MIP-2) with respect to the 
control/vehicle levels. Additionally, the specific splenic 
lymphocytes were reported to be reduced after the treatment. 
Cancer results in increased levels of cytokines, which were 
was siginificantly reduced by the human Biofield Therapy 
[49]. As per the U. S. Department of Health and Human 
Services and Centers for Disease Control and Prevention 
(CDC), 34% of adults in the U. S. A. depend upon some kind 
of complementary or alternative health care approach, such 
as energy medicine. Complementary and alternate medicine 
has several advantages over the current allopathic model of 
treatment. These energy therapies are well defined by 
National Center for Complementary and Integrative Health 
(NCCIH), a subdivision of the National Institutes of Health 
(NIH), and come under the category of energy medicine [50]. 
In this study, the anti-inflammatory effect of the Biofield 
Treated formulation was screened by assessing the metabolic 
activity of immune cells using MTT assay. The Biofield 
Energy Treatment is regarded as more rapid, less costly, and 
less time consuming because it was reported to show similar 
results as the bromodeoxyuridine (BrdU) assay, such as cell 
proliferation, cell growth, and metabolic activity as the 
reports suggest [51]. The anti-inflammatory effect of both the 
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Biofield Energy Treated and untreated test formulations were 
evaluated in two different immune cells from the mice. MTT 
assay was carried out in order to evaluate non-cytotoxic 
concentrations of the test formulation. The metabolic activity 
is evaluated using the MTT test by measuring the activity of 
succinate dehydrogenase, a mitochondrial enzyme. This test 
is widely used in the in vitro evaluation of the toxicity of any 
test item. Both DCs and splenocytes (immune cells) were 
exposed at various concentrations of the Biofield Treated and 
untreated test formulations for 24 hours and 48 hours, 
respectively. No sign of negative effects was observed after 
treatment with the tested concentrations (Figure 1 and 2). 
The concentrations higher than 105.2 µg/mL caused a 
significant reduction in the DCs viability and splenocyte cells 
were showed cytotoxic at 10.5 µg/mL. 
The Biofield Energy Treated formulation demonstrated the 
greatest potential for modulating the inflammatory response 
of DC and splenocyte cells in in vitro assays. There was a 
significant reduction of TNF-α, MIP-1α and IL-1β levels in 
the cell supernatants of all tested concentrations. Importantly, 
these effects were not attributable to decrease in cellular 
viability indicating that this product was not adversely 
affecting the cultured murine DCs and splenocyte cells. 
Therefore, these results suggest that Biofield Energy Treated 
formulation may inhibit the inflammatory responsiveness of 
DCs and splenocyte cells by modulating signal transduction 
pathways involved in the generation of NO, IL-6 and TNF-α. 
This effect may be the result of specific inhibition of NF-κB, 
a transcription factor involved in the activation of many 
inflammatory mediator genes. It is worthwhile to note that 
the anti-inflammatory effects of the Biofield Energy Treated 
formulation were not limited to only DCs, on the other hand 
the Biofield Treated formulation also elicited suppressive 
effects in LPS stimulated mice splenocyte cells on pro-
inflammatory cytokines (TNF-α, MIP-1α and IL-1β) 
production, which is another important population of innate 
immune cells that function as antigen presenting cells 
(APCs). Several cytokines are deeply associated with 
inflammatory diseases, so LPS was used in the study to 
induce the immune system, as it creates the disease 
condition. In particular, TNF-α and IL-1β are prominent 
contributors to chronic inflammatory disorders. TNF-α and 
IL-1 β receptor antagonists have been clinically successful to 
improve the symptoms of rheumatoid arthritis patients. 
Steroids, such as prednisolone and dexamethasone, are 
known to reduce the production of these cytokines, but have 
many associated side effects. 
Collectively, our data suggest that the Biofield Energy 
Treated formulation may act as an effective anti-inflammatory 
product with little-to-no toxicity. The results of the Biofield 
Energy Treated formulation suggest better inhibition of T and 
B lymphocytes, which can be used in several applications 
related to immune-mediated disorders such as autoimmune 
disorder, stress, and asthma [52]. Because of its promising 
anti-inflammatory effects in vitro, the Biofield Treated 
herbomineral formulation would also be considered for 
different chronic inflammation and infectious diseases. 
5. Conclusions 
Based on these results, it was concluded that the Biofield 
Energy Treated formulation modulates the DCs and 
splenocyte cells function. Further, the Biofield Treated 
formulation significantly inhibited the activity of pro-
inflammatory cytokines such as TNF-α, MIP-1α, and IL-1β 
in both the tested immune cells as compared to the untreated 
test formulation. The results of MTT assay in DCs after 24 
hours of treatment incubation with different concentrations of 
the Biofield Treated formulation suggest a safe concentration 
range of 1.05 to 105.2 µg/mL, which was tested for 
estimation of TNF-α. Similarly, MTT assay in splenocyte 
cells after 48 hours of treatment incubation with the different 
concentrations of the Biofield Treated formulation in the 
presence of 0.5 µg/mL LPS, suggest that the concentration 
range of 0.0000105 to 1.05 µg/mL was found safe with more 
than 80% cell viability, which were selected for MIP-1α and 
IL-1β estimation. The Biofield Treated formulation showed 
significant (p≤0.001) suppression of TNF-α level in DCs 
cells at all the tested concentration ranges (i.e. 1.05 to 1052.5 
µg/mL), while maximum suppression was reported at 5.2 
µg/mL by 43.64% as compared with the untreated test 
formulation. However, the levels of MIP-1α and IL-1β at the 
tested concentration range (0.0000105 to 10.5 µg/mL) in LPS 
stimulated splenocyte cells were significantly inhibited. 
Further, data suggests that inhibition of MIP-1α (26.52%) 
and IL-1β (35.28%) in the Biofield Treated formulation at 
0.000105 and 0.0000105 µg/mL, respectively as compared 
with the untreated test formulation. 
Overall, the inhibition of pro-inflammatory cytokines 
might prevent the over activation of the human immune 
system. Thus, it may strongly counteract the pro-
inflammatory responses, which might prevent immune-
mediated tissue damage. Through insight into 
immunomodulatory cytokines, the Biofield Energy Treated 
test formulation can provide the innovative strategy to affect 
the immune system, which could help combat various acute 
and chronic inflamatory diseases as a better complementary 
and alternative medicine. So, it can be concluded that The 
Trivedi Effect
®
-Biofield Energy Healing (TEBEH) has the 
capacity to modulate the immunoinflammatory activity of 
herbomineral formulations with a safe therapeutic index and 
a faster absorption rate that can enhance the human well-
being in the biomedical health care system. This can be 
ulitized against many acute and chronic inflammatory 
diseases like Asthma, Chronic peptic ulcer, Tuberculosis, 
Hepatitis, Irritable Bowel Syndrome, Parkinson’s Disease, 
Rheumatoid arthritis, Chronic periodontitis, Ulcerative colitis, 
Crohn's disease, Chronic sinusitis, Systemic Lupus 
Erythematosus, Type 1 Diabetes and Chronic active hepatitis. 
Furthermore, the Biofield Energy Treatment Therapy applied 
to the herbomineral formulation can also be utilized for 
various autoimmune disorders such as Graves’ Disease, 
Lupus, Celiac Disease (gluten-sensitive enteropathy), 
Dermatomyositis, Hashimoto Thyroiditis, Addison Disease, 
Multiple Sclerosis (MS), Myasthenia Gravis, Aplastic 
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Anemia, Reactive Arthritis, Sjogren Syndrome, Alopecia 
Areata, Fibromyalgia, Vitiligo, Pernicious Anemia, Psoriasis, 
Scleroderma, Chronic Fatigue Syndrome and Vasculitis, as 
well as to prevent the immune-mediated tissue damage in 
cases of organ transplants (for example kidney transplants, 
liver transplants and heart transplants) because of its safe 
therapeutic index and potential to modulate the immune 
system and improve overall health and quality of life. Overall, 
the Biofield Energy Healing Treated test formulation can 
also be used for anti-aging, stress prevention and 
management, and in the improvement of overall health and 
quality of life. 
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